Ko Abe

578 total citations
18 papers, 414 citations indexed

About

Ko Abe is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Ko Abe has authored 18 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Ko Abe's work include Mitochondrial Function and Pathology (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Ferroptosis and cancer prognosis (2 papers). Ko Abe is often cited by papers focused on Mitochondrial Function and Pathology (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Ferroptosis and cancer prognosis (2 papers). Ko Abe collaborates with scholars based in Japan, Norway and United States. Ko Abe's co-authors include Hiroyuki Tsutsui, Masataka Ikeda, Shouji Matsushima, Tomomi Ide, Hiroko Deguchi Miyamoto, Tomonori Tadokoro, Hirotaka Imai, Ken‐ichi Yamada, Tomoko Koumura and Tomokatsu Hori and has published in prestigious journals such as SHILAP Revista de lepidopterología, Science Signaling and Journal of the American Heart Association.

In The Last Decade

Ko Abe

16 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ko Abe Japan 10 191 190 113 77 62 18 414
Gamal Andre Banat Germany 5 322 1.7× 260 1.4× 92 0.8× 84 1.1× 31 0.5× 6 592
Xingen Zhu China 12 89 0.5× 189 1.0× 100 0.9× 31 0.4× 45 0.7× 37 389
Amy Watkins United Kingdom 10 145 0.8× 124 0.7× 46 0.4× 95 1.2× 25 0.4× 17 405
R. Ballester Spain 12 76 0.4× 130 0.7× 95 0.8× 35 0.5× 148 2.4× 19 390
Roman Makarewicz Poland 12 127 0.7× 122 0.6× 106 0.9× 23 0.3× 53 0.9× 73 461
Ioana Molnar France 13 167 0.9× 117 0.6× 46 0.4× 24 0.3× 54 0.9× 55 508
Paola Ferro Italy 15 200 1.0× 132 0.7× 81 0.7× 76 1.0× 19 0.3× 50 588
Marcus Stockinger Germany 9 70 0.4× 134 0.7× 124 1.1× 23 0.3× 59 1.0× 19 311
Paulo Príncipe Portugal 9 192 1.0× 156 0.8× 193 1.7× 49 0.6× 14 0.2× 12 438
Huasong Feng China 10 222 1.2× 123 0.6× 36 0.3× 17 0.2× 54 0.9× 12 436

Countries citing papers authored by Ko Abe

Since Specialization
Citations

This map shows the geographic impact of Ko Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Abe more than expected).

Fields of papers citing papers by Ko Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ko Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Abe. The network helps show where Ko Abe may publish in the future.

Co-authorship network of co-authors of Ko Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Ko Abe. A scholar is included among the top collaborators of Ko Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko Abe. Ko Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ikeda, Masataka, Ko Abe, Satoshi Fujita, et al.. (2025). Excessive HIF-1α driven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxia. Nature Cardiovascular Research. 4(9). 1077–1093. 1 indexed citations
2.
Abe, Ko, Sho Ikeda, Miho Nara, et al.. (2023). Hypoxia‐induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase‐1 in multiple myeloma. Cancer Medicine. 12(8). 9709–9722. 9 indexed citations
3.
Ikeda, Masataka, Hiroko Deguchi Miyamoto, Ko Abe, et al.. (2023). Deferasirox Targeting Ferroptosis Synergistically Ameliorates Myocardial Ischemia Reperfusion Injury in Conjunction With Cyclosporine A. Journal of the American Heart Association. 13(1). e031219–e031219. 26 indexed citations
4.
Ikeda, Masataka, Tomomi Ide, Hiroko Deguchi Miyamoto, et al.. (2023). Cardiac Autoantibodies Against Cardiac Troponin I in Post-Myocardial Infarction Heart Failure: Evaluation in a Novel Murine Model and Applications in Therapeutics. Circulation Heart Failure. 16(10). e010347–e010347. 5 indexed citations
5.
Ikeda, Masataka, Tomomi Ide, Shouji Matsushima, et al.. (2022). Immunomodulatory Cell Therapy Using αGalCer-Pulsed Dendritic Cells Ameliorates Heart Failure in a Murine Dilated Cardiomyopathy Model. Circulation Heart Failure. 15(12). e009366–e009366. 14 indexed citations
6.
Abe, Ko, Masataka Ikeda, Tomomi Ide, et al.. (2022). Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis. Science Signaling. 15(758). eabn8017–eabn8017. 88 indexed citations
7.
Tadokoro, Tomonori, Masataka Ikeda, Ko Abe, et al.. (2022). Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity. Journal of Cardiovascular Pharmacology. 80(5). 690–699. 28 indexed citations
8.
Miyamoto, Hiroko Deguchi, Masataka Ikeda, Tomomi Ide, et al.. (2022). Iron Overload via Heme Degradation in the Endoplasmic Reticulum Triggers Ferroptosis in Myocardial Ischemia-Reperfusion Injury. JACC Basic to Translational Science. 7(8). 800–819. 100 indexed citations
9.
Ikeda, Masataka, Tomomi Ide, Tomonori Tadokoro, et al.. (2021). Excessive Hypoxia‐Inducible Factor‐1α Expression Induces Cardiac Rupture via p53‐Dependent Apoptosis After Myocardial Infarction. Journal of the American Heart Association. 10(17). e020895–e020895. 26 indexed citations
10.
Ikeda, Masataka, Tomomi Ide, Tomonori Tadokoro, et al.. (2021). Heart Rate Reduction with Ivabradine Prevents Cardiac Rupture after Myocardial Infarction in Mice. Cardiovascular Drugs and Therapy. 36(2). 257–262. 13 indexed citations
11.
Teshima, Kazuaki, Masaaki Kume, Kenichi Shibata, et al.. (2021). Methotrexate-induced Transient Encephalopathy in an Adolescent and Young Adult Patient with Acute Lymphoblastic Leukemia. Internal Medicine. 60(13). 2115–2118. 2 indexed citations
12.
Hosokawa, Kazuya, Ko Abe, Toshiaki Kadokami, et al.. (2020). Changes in lung to finger circulation time measured via cardiopulmonary polygraphy in patients with varying types of heart disease. Heart and Vessels. 36(1). 58–68. 2 indexed citations
13.
Teshima, Kazuaki, Masaaki Kume, Takashi Saito, et al.. (2020). CD7-Positive Diffuse Large B-Cell Lymphoma Presenting as an Intranasal Tumor. SHILAP Revista de lepidopterología. 2020. 1–4.
15.
Ono, Yuko, Ko Abe, Kazufumi Suzuki, et al.. (2013). Usefulness of 4D-CTAin the Detection of Cerebral Dural Sinus Occlusion or Stenosis with Collateral Pathways. The Neuroradiology Journal. 26(4). 428–438. 10 indexed citations
16.
Chernov, Mikhail, M. Hayashi, Masahiro Izawa, et al.. (2005). Differentiation of the Radiation-Induced Necrosis and Tumor Recurrence after Gamma Knife Radiosurgery for Brain Metastases: Importance of Multi-Voxel Proton MRS. min - Minimally Invasive Neurosurgery. 48(4). 228–234. 80 indexed citations
17.
Ono, Yuko, Ko Abe, Takashi Maruyama, et al.. (2003). Combination of Functional MRI and Diffusion Tensor Imaging in the Treatment of the Malignant Gliomas. Rivista di Neuroradiologia. 16(6). 1079–1080.
18.
Narai, Hisashi, et al.. (2001). Serial MRI findings in patient with chronic cryptococcus meningo-encephalitis. Neurological Research. 23(8). 810–812. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026